Abstract
Clinical trials have evaluated the overall efficacy of surfactant therapy, as well as the relative efficacy of different surfactant preparations, the optimal timing of administration and the optimal dosage. Surfactant therapy leads to significant clinical improvement in infants at risk for, or having, respiratory distress syndrome (RDS). Clinical trials that compared the effects of synthetic or animal-derived surfactant preparations to placebo or no therapy demonstrate that surfactant therapy lead to rapid improvement in oxygenation, decreased ventilator support, decreased risk of pneumothorax, and mortality. Earlier treatment, prophylactic treatment of infants at high risk of developing RDS, and selective re-treatment leads to improved clinical outcome as well. Currently available animal-derived surfactants are superior to non-protein-containing synthetic surfactants. Ongoing evaluation will determine if important differences in animal-derived products are noted. Future trials will evaluate third-generation surfactant products and further refine what constitutes optimal use of surfactant.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bhat R, Dziedzic K, Bhutani VK, Vidyasagar D . Effect of single dose surfactant on pulmonary function. Crit Care Med 1990;18(6):590–595.
Bhutani VK, Abbasi S, Long WA, Gerdes JS . Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J Pediatr 1992;120(2 Part 2):S18–S24.
Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ . Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. J Pediatr 1990;116(1):119–124.
Soll RF . Surfactant treatment of the very preterm infant. Biol Neonate 1998;74(Suppl):35–42.
Soll RF . Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants (Cochrane Review) In: The Cochrane Library. Issue 3. Oxford: Update Software; 2003.
Soll RF . Synthetic surfactant for respiratory distress syndrome in preterm infants (Cochrane Review) In: The Cochrane Library. Issue 3. Oxford: Update Software; 2003.
Soll RF . Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants (Cochrane Review) In: The Cochrane Library. Issue 3. Oxford: Update; Software 2003.
Doyle LW, Gultom E, Chuang SL, James M, Davis P, Bowman E . Changing mortality and causes of death in infants 23–27 weeks' gestational age. J Pediatr Child Health 1999;35(3):255–259.
Hamvas A, Wise PH, Yang RK, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. New Engl J Med 1996;334(25):1635–1640.
Hoekstra RE, Ferrara TB, Payne NR . Effects of surfactant therapy on outcome of extremely premature infants. Eur J Pediatr 1994;153((9 Suppl 2):S12–S16.
Horbar JD, Wright EC, Onstad L . Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. The Members of the National Institute of Child Health and Human Development Neonatal Research Network. Pediatrics 1993;92(2):191–196.
Lee K, Khoshnood B, Wall SN, Chang Y, Hsieh HL, Singh JK . Trend in mortality from respiratory distress syndrome in the United States, 1970–1995. J Pediatr 1999;134(4):434–440.
Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ . Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. New Engl J Med 1994;330(21):1476–1480.
Corbet A, Long W, Schumacher R, Gerdes J, Cotton R . Double-blind developmental evaluation at 1-year corrected age of 597 premature infants with birth weights from 500 to 1350 grams enrolled in three placebo-controlled trials of prophylactic synthetic surfactant. American Exosurf Neonatal Study Group I. J Pediatr 1995;126(5 Part 2):S5–12.
Courtney SE, Long W, McMillan D, et al. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups. J Pediatr 1995;126(5 Part 2):S43–S52.
Dunn MS, Shennan AT, Hoskins EM, Lennox K, Enhorning G . Two-year follow-up of infants enrolled in a randomized trial of surfactant replacement therapy for prevention of neonatal respiratory distress syndrome. Pediatrics 1988;82(4):543–547.
Ferrara TB, Hoekstra RE, Couser RJ, et al. Effects of surfactant therapy on outcome of infants with birth weights of 600 to 750 grams. J Pediatr 1991;119(3):455–457.
Robertson B, Curstedt T, Tubman R, et al. A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group. Eur J Pediatr 1992;151(5):372–376.
Wagner CL, Kramer BM, Kendig JW, et al. School-age follow-up of a single-dose prophylactic surfactant cohort. J Dev Behav Pediat 1995;16(5):327–332.
Ware J, Taeusch HW, Soll RF, McCormick MC . Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics 1990;85(6):1103–1107.
Robertson B, Halliday HL . Principles of surfactant replacement. Biochim Biophys Acta 1998;1408:346–361.
Choukroun ML, Llanas B, Apere H, et al. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Pediatr Pulmonol 1994;18(5):273–278.
Hudak ML, Farrell EE, Rosenberg AA, et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996;128(3):396–406.
Modanlou HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV . Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity. J Perinatol 1997;17(6):455–460.
Rollins M, Jenkins J, Tubman R, Corkey C, Wilson D . Comparison of clinical responses to natural and synthetic surfactants. J Perinat Med 1993;21(5):341–347.
Soll RF, Blanco F . Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome (Cochrane Review) In: The Cochrane Library. Issue 3. Oxford: Update Software; 2003.
Ainsworth SB, Beresford MW, Milligan DW, et al. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25–29 weeks' gestation: a randomised trial. Lancet 2000;355(9213):1387–1392.
Alvarado M, Hingre R, Hakason D, Gross S . Clinical trial of Survanta versus Exosurf in infants <1500 g with respiratory distress syndrome. Pediatr Res 1993;33:314A.
Da Costa DE, Pai MG, Al Khusaiby SM . Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. Pediatr Pulmonol 1999;27(5):312–317.
Horbar JD, Wright LL, Soll RF, et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993;123(5):757–766.
Kukkonen AK, Virtanen M, Jarvenpaa AL, Pokela ML, Ikonen S, Fellman V . Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 2000;89:556–561.
Pearlman SA, Leef KH, Stefano Jl, et al. A randomized trial comparing Exosurf versus Survanta in the treatment of neonatal RDS. Pediatr Res 1993;33:340A.
Sehgal SS, Ewing CK, Richards T, Taeusch HW . Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc 1994;86(1):46–52.
Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996;97(1):1–6.
Bloom BT, Kattwinkel J, Hall RT, et al. Comparison of Infasurf (Calf Lung Surfactant Extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome. Pediatrics 1997;100:31–38.
Speer CP, Gefeller O, Groneck P, et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1995;72(1):F8–13.
Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K . A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol 2004;21(3):109–119.
Broadbent R, Fok TF, Dolovich M, et al. Chest position and pulmonary deposition of surfactant in surfactant depleted rabbits. Arch Dis Child Fetal Neonatal Ed 1995;72(2):F84–F89.
Segerer H, van Gelder W, Angenent FW, et al. Pulmonary distribution and efficacy of exogenous surfactant in lung-lavaged rabbits are influenced by the instillation technique. Pediatr Res 1993;34:490–494.
Ueda T, Ikegami M, Rider ED, et al. Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 1994;76:45–55.
Fok TF, al Essa M, Dolovich M, Rasid F, Kirpalani H . Nebulisation of surfactants in an animal model of neonatal respiratory distress. Arch Dis Child Fetal Neonatal Ed 1998;78(1):F3–F9.
Petrikovsky BM, Lysikiewicz A, Markin LB, Slomko Z . In utero surfactant administration to preterm human fetuses using endoscopy. Fetal Diagnosis Ther 1995;10(2):127–130.
Dunn MS, Shennan AT, Possmayer F . Single- versus multiple-dose surfactant replacement therapy in neonates of 30 to 36 weeks' gestation with respiratory distress syndrome. Pediatrics 1990;86(4):564–571.
Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992;89(1):13–20.
Soll RF . Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome (Cochrane Review). In: The Cochrane Library. Issue 3. Oxford: Update Software; 2003.
The OSIRIS Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant — The judgment of OSIRIS. Open study of infants at high risk of or with respiratory insufficiency — the role of surfactant. Lancet 1992;340(8832):1363–1369.
Dunn MS, Shennan AT, Zayack D, Possmayer F . Bovine surfactant replacement therapy — a comparison of 2 retreatment strategies in premature infants with RDS. Pediatr Res 1991;29(4 Part 2):212A.
Kattwinkel J, Bloom BT, Delmore P, et al. High- versus low-threshold surfactant retreatment for neonatal respiratory distress syndrome. Pediatrics 2000;106(2 Part 1):282–288.
Jobe A, Ikegami M, Jacobs H, et al. Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant. J Clin Invest 1984;73:848–856.
Seidner SR, Ikegami M, Yamada T, Rider ED, Castro R, Jobe AH . Decreased surfactant dose-response after delayed administration to preterm rabbits. Am J Respir Crit Care Med 1995;152(1):113–120.
Ikegami M, Wada K, Emerson GA, et al. Effects of ventilation style on surfactant metabolism and treatment response in preterm lambs. Am J Respir Crit Care Med 1998;157:638–644.
Jobe AH, Ikegami M . Surfactant and acute lung injury. Proc Assoc Am Phys 1998;110:489–495.
Bevilacqua G, Parmigiani S, Robertson B . Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial. J Perinat Med 1996;24(6):609–620.
Bevilacqua G, Chernev T, Parmigiani S, et al. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial. Acta Bio-Med Ateneo Parmense 1997;68(Suppl 1):47–54.
Dunn MS, Shennan AT, Zayack D, Possmayer F . Bovine surfactant replacement therapy in neonates of less than 30 weeks' gestation: a randomized controlled trial of prophylaxis versus treatment. Pediatrics 1991;87(3):377–386.
Egberts J, de Winter JP, Sedin G, et al. Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. Pediatrics 1993;92(6):768–774.
Kattwinkel J, Bloom BT, Delmore P, et al. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Pediatrics 1993;92(1):90–98.
Kendig JW, Notter RH, Cox C, et al. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks' gestation. New Engl J Med 1991;324(13):865–871.
Merritt TA, Hallman M, Berry C, et al. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr 1991;118(4 Part 1):581–594.
Walti H, Paris-Llado J, Breart G, Couchard M . Porcine surfactant replacement therapy in newborns of 25–31 weeks' gestation: a randomized, multicentre trial of prophylaxis versus rescue with multiple low doses. The French Collaborative Multicentre Study Group. Acta Paediatr 1995;84(8):913–921.
Kattwinkel J . Surfactant: evolving issues. Clin Perinatol 1998;25:17–32.
Halliday HL . Prophylactic surfactant for preterm infants In: Cockburn F, editor. Advances in Perinatal Medicine. Lancaster: Parthenon Press; 1997 qpp. 360–370.
Kendig JW, Ryan RM, Sinkin RA, et al. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics 1998;101(6):1006–1012.
European Exosurf Study Group. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. Online J Curr Clin Trials 1992 Doc No 28:3886.
Gortner L, Wauer RR, Hammer H, et al. Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial. Pediatrics 1998;102(5):1153–1160.
Konishi M, Fujiwara T, Chida S, et al. A prospective, randomized trial of early versus late administration of a single dose of surfactant-TA. Early Hum Dev 1992;29(1–3):275–282.
Yost CC, Soll RF . Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome (Cochrane Review) In: The Cochrane Library. Issue 3. Oxford: Update Software; 2003.
Author information
Authors and Affiliations
Additional information
Disclosure: Research Support: Beiersdorf Medical, NICHHD, Ross Laboratories: Employee: Vice President, Vermont Oxford Network and Director of Clinical Trials. Consultant: Abbott Laboratories, Arizeke, Burroughs-Wellcome, Chiesi Pharmaceuticals, DEY, L.P., Inhibitex, Ross Laboratories
Rights and permissions
About this article
Cite this article
Suresh, G., Soll, R. Overview of Surfactant Replacement Trials. J Perinatol 25 (Suppl 2), S40–S44 (2005). https://doi.org/10.1038/sj.jp.7211320
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211320
This article is cited by
-
Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?
Pediatric Research (2023)
-
RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS
Journal of Perinatology (2023)
-
Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants
Pediatric Research (2023)
-
A pilot study of evaluation of semi-rigid and flexible catheters for less invasive surfactant administration in preterm infants with respiratory distress syndrome—a randomized controlled trial
BMC Pediatrics (2022)
-
Outcomes associated with surfactant in more mature and larger premature infants with respiratory distress syndrome
Journal of Perinatology (2020)